International Stem Cell Corporation Announces 1:150 Reverse Stock Split

CARLSBAD, CA–(Marketwired – July 28, 2015) – International Stem Cell Corporation (ISCO), a California-based biotechnology company developing novel stem cell based therapies and biomedical products, announced today that it will complete a 1:150 reverse …

[Read the full article here]

Comments are closed.